67 related articles for article (PubMed ID: 1930089)
1. The influenza virus-infected host cell, a target for the immune response.
Becht H; Weiss HP
Behring Inst Mitt; 1991 Jul; (89):1-11. PubMed ID: 1930089
[TBL] [Abstract][Full Text] [Related]
2. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
[TBL] [Abstract][Full Text] [Related]
3. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T lymphocyte response.
Kuwano K; Scott M; Young JF; Ennis FA
J Immunol; 1988 Feb; 140(4):1264-8. PubMed ID: 2449498
[TBL] [Abstract][Full Text] [Related]
4. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.
Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ
J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942
[TBL] [Abstract][Full Text] [Related]
5. Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72.
Saikh KU; Martin JD; Nishikawa AH; Dillon SB
Virology; 1995 Dec; 214(2):445-52. PubMed ID: 8553546
[TBL] [Abstract][Full Text] [Related]
6. Cytolytic T lymphocyte and antibody responses to synthetic peptides of influenza virus hemagglutinin.
Wabuke-Bunoti MA; Taku A; Fan DP; Kent S; Webster RG
J Immunol; 1984 Oct; 133(4):2194-201. PubMed ID: 6206156
[TBL] [Abstract][Full Text] [Related]
7. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
8. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence.
Townsend AR; Bastin J; Gould K; Brownlee GG
Nature; 1986 Dec 11-17; 324(6097):575-7. PubMed ID: 3491325
[TBL] [Abstract][Full Text] [Related]
10. Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin.
Hioe CE; Hinshaw VS
J Immunol; 1989 Apr; 142(7):2482-8. PubMed ID: 2466897
[TBL] [Abstract][Full Text] [Related]
11. Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus.
Jackson DC; Drummer HE; Brown LE
Virology; 1994 Feb; 198(2):613-23. PubMed ID: 7507281
[TBL] [Abstract][Full Text] [Related]
12. A monoclonal antibody produced during infection which recognizes an epitope of influenza hemagglutinin only in the context of H-2k MHC class I antigen.
McLain L; Dimmock NJ
J Immunol; 1993 Apr; 150(8 Pt 1):3421-6. PubMed ID: 7682240
[TBL] [Abstract][Full Text] [Related]
13. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin.
Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M
Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276
[TBL] [Abstract][Full Text] [Related]
15. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
[TBL] [Abstract][Full Text] [Related]
16. Fine specificity and antigen receptor expression among influenza virus-specific cytolytic T lymphocyte clones.
Braciale TJ; Henkel TJ; Lukacher A; Braciale VL
J Immunol; 1986 Aug; 137(3):995-1002. PubMed ID: 2424996
[TBL] [Abstract][Full Text] [Related]
17. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection.
Tite JP; Hughes-Jenkins C; O'Callaghan D; Dougan G; Russell SM; Gao XM; Liew FY
Immunology; 1990 Oct; 71(2):202-7. PubMed ID: 2172156
[TBL] [Abstract][Full Text] [Related]
18. [Development of synthetic peptide vaccine against influenza--T cell epitope the hemagglutinin of A/Aichi/2/68(H3N2) influenza virus induced immune response in mice].
Naruse H
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):811-20. PubMed ID: 7525436
[TBL] [Abstract][Full Text] [Related]
19. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
20. Isolation and immunogenic properties of a monomeric form of the HA1 subunit of the influenza virus haemagglutinin from infected cells.
Weber C; Scheepers K; Linder D; Becht H
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2793-7. PubMed ID: 8277289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
